Cellular Biomedicine Group Inc (NASDAQ:CBMG)

31.50
Delayed Data
As of 1:54pm ET
 +2.00 / +6.78%
Today’s Change
4.24
Today|||52-Week Range
38.99
+144.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$322.9M

Company Description

Cellular Biomedicine Group, Inc. is a biomedicine company. It engages in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The company's developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Cellular Biomedicine Group was founded on February 6, 2013 and is headquartered in Palo Alto, CA.

Contact Information

Cellular Biomedicine Group, Inc.
530 University Avenue
Palo Alto California 94301
P:(650) 566-5064
Investor Relations:

Employees

Shareholders

Individual stakeholders17.91%
Mutual fund holders0.21%
Other institutional0.10%

Top Executives

Wei CaoPresident, CEO, Chief Operating Officer & Director
Bizuo LiuChief Financial Officer & Secretary
Maxwell WangDirector-Medical Research
Mingyuan ZhouChief Scientist
Li ZhangVice President-Technology & Manufacturing

To view my watchlist

Not a member yet?

Sign up now for a free account